Among a cohort of adults with tuberculous meningitis, including 83% living with human immunodeficiency virus, we found that baseline C-reactive protein ≥40 mg/L independently predicts 3 times higher odds of severe disability or death at 8 weeks of antituberculous therapy. This evidence concerns the gene CRP and meningeal tuberculosis.